ong-term observation study for maxillary sinus floor augmentation using octa-calcium phosphate/collagen composite
Not Applicable
Recruiting
- Conditions
- alveolar bone atrophy
- Registration Number
- JPRN-UMIN000041464
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
The conditions of all dental implants were uneventful throughout the follow-up period. Augmented bone volume and changing rate of augmented bone volume were essentially unchanged following maturation of the OCP/Col-derived new bone. Mean marginal bone loss was 1.76 mm with the simultaneous approach, and 0.50 mm with the staged approach at five years postoperatively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are treated for bone metabolic diseases such as osteoporosis and who are taking bisphosphonate drugs
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method